PET imaging for hard-to-treat pituitary tumors
Part of Brain & nervous system, Cancer, Hormones & metabolism clinical trials.
This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a pituitary tumor that came back within 6 months after surgery and cannot be controlled with standard treatments or radiation.
- Your previous tumor had a Ki-67 index of 3% or higher (a measure of how fast the tumor grows).
- You have at least one tumor spot that can be seen on scans and could be removed, and you can lie still for 30-60 minutes for a PET scan.
- You do not take high-dose riboflavin (vitamin B2) supplements before the scan and you stay hydrated.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you have no severe allergies to the imaging agent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.
This trial tests a new PET scan tracer to find neuroendocrine tumors in the body. It may help doctors see where the tumors are and plan better treatment.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
This trial tests an experimental PET imaging drug, called 68Ga-GP-01, to see if it can help show tumors and any spread of the cancer. The study will give you the imaging drug, then take a PET/CT scan. You may join if you have a solid tumor and are scheduled for surgery or a laparoscopic exploration to confirm the cancer.
This trial tests whether a special PET scan using a radioactive tracer called 18FET can better show hormone-producing pituitary tumors when the standard MRI is unclear. If the scan lights up the tumor, it could help guide surgery or radiation to treat it.
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
Hear when a new Pituitary Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.